TLSI FY 2023 Earnings — TriSalus Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena

TLSITriSalus Life Sciences, Inc.

$175M

FY 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$19M+49.3% YoY

Gross Profit

$16M85.9% margin

Operating Income

-$54M-294.3% margin

Net Income

-$59M-320.7% margin

EPS (Diluted)

$-2.23

Cash Flow

Operating Cash Flow

-$51M

Free Cash Flow

-$51M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$25M

Total Liabilities

$52M

Stockholders' Equity

-$27M

Cash & Equivalents

$12M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$19M	$12M	+49.3%
Gross Profit	$16M	$10M	+56.9%
Operating Income	-$54M	-$36M	-49.5%
Net Income	-$59M	-$47M	-25.8%